Insulin Signalling, Action and Secretion

The pancreas recognises a constant rise in blood glucose concentration after carbs are consumed, digested, and absorbed, and produces insulin to drive an increase in glucose level in the bloodstream, a condition known as hyperglycemia. Type 1 diabetes is caused by a significant decrease in insulin production due to beta cell death caused by autoimmunity. Type-2 diabetes is a complex condition characterised by a progressive increase in insulin resistance and a lack of insulin production, resulting in overt hyperglycemia.

 

    Related Conference of Insulin Signalling, Action and Secretion

    July 29-30, 2025

    15th World Congress on Endocrinology and Diabetes

    Paris, France
    September 08-09, 2025

    3rd World congress and Expo on Diabetes

    Frankfurt, Germany
    October 27-28, 2025

    5th World Congress on Endocrine and Diabetes

    Madrid, Spain
    October 30-31, 2025

    5th Annual Summit on Diabetes and Endocrinology

    Paris, France
    November 03-04, 2025

    34th European Diabetes Congress

    Rome, Italy
    November 06-07, 2025

    8th Annual Meeting on Diabetes and Endocrinology

    Dubai, UAE
    November 20-21, 2025

    21st World Congress on Endocrinology & Diabetes

    Paris, France
    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands

    Insulin Signalling, Action and Secretion Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in